IMMB Stock UPDATES Immunotech Laborator (IMMB) 0.0200 08/03/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Immunotech Laborator (IMMB) 0.0200 $IMMB

Agile Therapeutics Announces Appointment of Science Advisory Board Member
PR Newswire - Thu Feb 13, 7:30AM CST
Agile Therapeutics, a specialty pharmaceutical company focused on women's health, announced today that Daniel A. Shames M.D., F.A.C.S., has joined its Scientific Advisory Board. Dr. Shames is an experienced clinician with extensive experience in pharmaceutical development and regulatory affairs. His experience includes over ten years of practice at the U.S. Food and Drug Administration (FDA) where he served as Deputy Director, Office of Drug Evaluation III/Center for Drug Evaluation and Research (CDER) from 2006 to 2008, as well as a member of the Senior Management Team of the Office of New Drugs and the Drug Safety Oversight Board. Since 2008, as President of Daniel A. Shames Consulting, Inc., he has been an independent clinical/regulatory consultant on a wide range of pharmaceutical issues. Dr. Shames began his career with the FDA in 1996 and held positions as Primary Medical Officer, Team Leader and Deputy Director in the Division of Reproductive and Urologic Products (DRUP). From 2001 to 2006, he served as Director of DRUP and reviewed therapeutic products for clinical areas including contraception, infertility, obstetrics, menopause and urinary incontinence for which he received the CDER Leadership Excellence Award. He later served as Director of the Division of Gastroenterology and Inborn Error Products from 2007 to 2008 where he received the FDA Outstanding Service Award for leadership.

What's Love Got to Do with It? Give Your Smartphone a Valentine's Gift This Year
PR Newswire - Wed Feb 12, 8:30AM CST
Whether planning a romantic night on the town with a sweetheart or a trip to the slopes to avoid Valentine's Day entirely, most tech users will admit they are in a serious relationship with their smartphone. Defend that love from all the bumps, dings and drops life throws at it with an OtterBox® protective case.

Bunge Purchases Corn Masa Flour Mill
PR Newswire - Fri Feb 07, 3:44PM CST
Bunge North America, the North American operating arm of Bunge Limited (NYSE: BG), announced that it has purchased the assets of Corn Flour Producers, LLC. Financial terms of the acquisition have not been released.

SupersonicAds Announces Three Key Leadership Hires In North America
PR Newswire - Wed Jan 29, 7:17AM CST
SupersonicAds-- one of the world's leading web and mobile app monetization platforms--today announced an expansion of its North American leadership team with the creation of three new positions based at the company's headquarters.

Immunotech Laboratories Inc. Corporate Update
ACCESSWIRE - Fri Jan 10, 8:01AM CST
MONROVIA, CA / ACCESSWIRE / January 10, 2014 / Immunotech Laboratories, Inc. (OTCMARKETS: IMMB) Immunotech Laboratories, Inc. today released the following company updates for Shareholders and Investors:

Immunotech Laboratories, Inc. Announces the Results From Gap Analysis Report
GlobeNewswire - Wed Jun 19, 8:05AM CDT
Immunotech Laboratories, Inc. (Pink Sheets:IMMB) today announced the results from Gap Analysis report.

Immunotech Laboratories ITV-1 Manufacturing Announcement
GlobeNewswire - Thu May 30, 8:09AM CDT
Immunotech Laboratories, Inc. (Pink Sheets:IMMB) today announced the company has reached advanced negotiations for the production of Immunotech's ITV-1 Medicine with a reputed Contract manufacturing facility, for use in the Bulgarian Clinical Studies. All costs related to the production of the ITV-1 for this production will be facilitated by Immunotech's sister company in Bulgaria. (Immunotech BG).

Immunotech Laboratories Corporate Shareholder Update Summary
GlobeNewswire - Thu May 09, 8:00AM CDT
Immunotech Laboratories, Inc. (Pink Sheets:IMMB) Immunotech Laboratories, Inc. today released the following company updates for shareholders and Investors:

Immunotech Laboratories, Inc. Provides Funding Update
GlobeNewswire - Mon Apr 29, 10:11AM CDT
Immunotech Laboratories, Inc. (Pink Sheets:IMMB) today announced that they are in preliminary discussions with a large potential funding group out of Dubai. The group has shown interest in the future development and support of the Company's future FDA clinical trials.

Immunotech Laboratories Begins Regulatory Process With US Food & Drug Administration
Marketwire - Fri Apr 26, 8:00AM CDT
Immunotech Laboratories, Inc. (PINKSHEETS: IMMB) today announced the company has initiated the Pre-IND and IND process with the US Food & Drug Administration (FDA). The successful submission of an Investigational New Drug (IND) to FDA will permit Immunotech to conduct clinical trials designed to result in marketing approval for a new drug.

Immunotech Laboraties Appoints New VP of Business Development
Marketwire - Mon Apr 15, 8:25AM CDT
Immunotech Laboratories, Inc. (PINKSHEETS: IMMB) announces the company has appointed Blaine Nabors as VP of Business Development.

Immunotech Laboraties Retains The Lebrecht Group to Upgrade the Company to Fully Reporting Status
Marketwire - Mon Apr 08, 8:54AM CDT
Immunotech Laboratories, Inc. (PINKSHEETS: IMMB) today announced the company signed an agreement with The Lebrecht Group, a professional law corporation, to provide legal services for Immunotech and to upgrade the company to OTC:BB fully reporting current status.

Immunotech Laboraties in Discussions for Pre-"IND" Testing of Aids-HIV "IPF" Treatment in the USA
Marketwire - Mon Mar 18, 8:01AM CDT
Immunotech Laboratories, Inc. (PINKSHEETS: IMMB) today announced the company has begun discussions with a professional medical consulting group to start the process for Pre-IND (Investigational New Drug) application in the USA.

Immunotech Founder & Chief Scientific Officer Harry Zhabilov Comments on Recent HIV Baby Cure Medicine
Marketwire - Tue Mar 12, 9:46AM CDT
Immunotech Laboratories, Inc. (PINKSHEETS: IMMB) Immunotech Company Founder & Chief Scientific Officer Harry Zhabilov comments on the recent AIDS-HIV Baby Cure Treatments.

Immunotech Announces Canadian Special Access Program Could Allow Legal Treatment of Company's Patented (IPF-ITV-1) AIDS-HIV Treatment
Marketwire - Thu Mar 07, 8:12AM CST
Immunotech Laboratories, Inc. (PINKSHEETS: IMMB) today announced the company has entered negotiations with a Canadian Wellness Organization for the use of Immunotech's Patented AIDS-HIV Treatment.

Immunotech Relocates to New Research & Development Laboratory Facility
Marketwire - Fri Mar 01, 8:15AM CST
Immunotech Laboratories, Inc. (PINKSHEETS: IMMB) today announced the company has relocated to a new Research & Development Lab facility in Monrovia, California.

Immunotech Laboratories Inc. Announces Clinical Trials Updates For Company's AIDS-HIV "IPF" Medicines
PR Newswire - Wed Feb 20, 12:32PM CST
Immunotech Laboratories, Inc. (PINKSHEETS: IMMB) Today announced the following updates for the International Clinical Trials of the company's patented AIDS-HIV "IPF" Medicine(s).

Immunotech Laboratories, Inc. Announces Analyst Report Issued by Market Advisors, Inc.
Marketwire - Tue Feb 19, 8:15AM CST
A research report has been issued by Market Advisors, Inc. "Fundamental Analysis for Today's Investments" on Immunotech Laboratories, Inc (PINKSHEETS: IMMB).

Dr. Oz, Host Of The Dr. Oz Show, and Harry Zhabilov Of Immunotech Laboratories Discuss Immunotherapy Treatments For Cancer, HIV/AIDS
PR Newswire - Wed Feb 06, 10:06AM CST
Recently www.UndiscoveredCompanies.com was able to ask Dr. Mehmet Oz, host of the Dr. Oz show and Harry Zhabilov, President of Immunotech Laboratories (PINKSHEETS:IMMB) about Immunotherapy Treatments and how they are used to treat patients suffering with Cancer, and HIV/AIDS Virus.

Immunotech Laboratories (IMMB) Patented "IPF" Technology A Serious Contender In The Race For HIV & Cancer Cures
PR Newswire - Mon Feb 04, 8:20AM CST
CSNNewswire/Immunotech Laboratories, Inc. (PINKSHEETS:IMMB)



Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fall Pest Risks Linger as Mild Weather Extends Threat

Updated Category News Views 64

A cold snap is not a magic off switch for mosquitoes, ticks, or rodents, and that is the sober point behind the National Pest Management Association's fall and winter 2026 Public Health Pest Index. The group is flagging conditions, not predicting that every household in a named city will face an infestation or illness. Still, mild temperatures, rain, flooding, and plenty...

Continue Reading
Linq's $90M Bet on the Infrastructure Behind AI Agents

Updated Category News Views 96

Ninety million dollars just landed on the least glamorous part of the AI-agent rush: the pipes. Linq, the San Francisco private company, announced the round on November 18, 2026, led by Andreessen Horowitz, with returning backing from TQ Ventures, Mucker Capital and Abstract, plus new money from Anthos and Left Lane Capital. Ben Horowitz is joining the board. That is a...

Continue Reading
Hyster-Yale’s $135 Million Convert Carries Real Cost

Updated Category News Views 48

Forklift makers do not usually get to hide a 7.50% borrowing cost behind glossy financing jargon. Hyster-Yale has priced $135 million of convertible senior notes due in 2031, lifting the deal from the originally announced $125 million. There is also an option for initial purchasers to take another $20 million. For NYSE:HY shareholders, this is not a simple debt cleanup....

Continue Reading
CloudBackend's €6.6M Test: Can Vibe Code Become SaaS?

Updated Category News Views 222

A prototype is cheap theatre; keeping it alive after customers arrive is where the bill lands. CloudBackend has raised €6.6 million to attack that unglamorous, absolutely vital stretch between an AI-made app and an actual software business. The round is led by Carl-Henric Svanberg's family office, while existing backer M2 Asset Management increased its stake. That is a...

Continue Reading
JLL’s Facility Management Push Gets a Useful Nod From Frost

Updated Category News Views 104

A Building Breaks Down Long Before the Earnings Call Notices Facility management is the sort of business that gets ignored until an airport system fails, a data-center cooling unit balks, or a workforce cannot use the building it was told to return to. That is why Frost & Sullivan’s 2026 recognition of JLL deserves more than the usual award-season shrug. It points to an...

Continue Reading
Subaru's 650-Car Anniversary Bet Is Delightfully Small

Updated Category News Views 98

Gold brake calipers may sound like a fussy correction, yet that little detail tells you exactly who Subaru is trying to please. The company has revised its announcement for the 2027 WRX tS GD25 and BRZ tS ZC15, clarifying the anniversary-model names and changing the WRX description from red-painted to gold-painted Brembo calipers. Nobody should confuse a corrected paint...

Continue Reading
Hisense Year-End Push Tests Its Connected-Home Pitch

Updated Category News Views 98

A 300-inch picture is one heck of a way to sell a refrigerator. Hisense is rolling out year-end offers across the Middle East and Africa that stitch together its premium displays, connected appliances and ConnectLife software under one big household-upgrade pitch. It is glossy stuff, sure, but there is a practical commercial question underneath all the sparkle: can the...

Continue Reading
Lithium's Next Leg Depends on Storage, Not EV Hype

Updated Category News Views 136

Grid batteries are quietly becoming lithium’s second engine, and that matters more than another flashy electric-vehicle sales headline. The market is projected to rise from $40.87 billion in 2026 to $57.77 billion by 2031, a 7.2% compound annual growth rate. Respectable growth, certainly. But this is not a straight line, and anybody treating a five-year market forecast...

Continue Reading
Neusoft's OneCoreGo Win Puts Auto Software in Focus

Updated Category News Views 30

A Dashboard Award Is Not Just About Pretty Pixels Crystal-like graphics and augmented-reality pathways may sound like the sort of thing a marketing department dreams up after too much coffee, but the more interesting bit in Neusoft's latest news is the machinery underneath. OneCoreGo 7.0 has received the Red Dot Design Award after taking a German iF Design Award earlier...

Continue Reading
Health In Tech Brings a Tech Veteran Onto Its Board

Updated Category News Views 126

Board appointments rarely make the cash register ring, but they can tell you where management thinks the next bruises are coming from. Health In Tech has added Tim Cortes as an independent director, put him in charge of the Compensation Committee, and placed him on both the Audit and Nominating and Corporate Governance Committees. For an AI-enabled insurance technology...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Scaling New Heights: S&P 500's Path to 6,500

Updated Category News Views 260

Market Rally Highlights The financial markets witnessed an impressive surge recently, with significant recoveries noted in leading indexes. The S&P 500, a crucial gauge for large-cap stocks, notably rose by 10.6% during the second quarter of the year. Many factors contributed to this remarkable increase, underscoring investor confidence despite some ongoing challenges in...

Continue Reading
Pultruded Spar Cap Market Growth: Forecasting US$ 2.1 Billion

Updated Category News Views 194

Insights into the Pultruded Spar Cap Market and Future Growth The Pultruded Spar Cap Market is on the cusp of significant expansion, with projections suggesting a robust annual growth rate of 16.7% from 2024 through 2030. Industry analyses indicate that this favorable trend could lead to a market size of US$ 2.1 billion by the end of the projection period. This report is...

Continue Reading
Irritable Bowel Syndrome Treatment Growth Projections 2033

Updated Category News Views 107

Irritable Bowel Syndrome: An Overview Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that can significantly affect a person's quality of life, leading to a range of uncomfortable symptoms such as abdominal discomfort, bloating, and irregular bowel movements. With various subtypes like IBS with Diarrhea (IBS-D) and IBS with Constipation (IBS-C), it...

Continue Reading
Anoto Group Reports Second Quarter Results 2024

Updated Category News Views 242

Overview of the Interim Report for 2024 The interim report covering January to June 2024 provides important insights into Anoto Group AB's operations and financial health. Anoto Group continues to be a leader in technology, particularly in optical recognition and digital writing. This report emphasizes key financial metrics and the company's strategic initiatives in a...

Continue Reading
Mission Critical Group Welcomes Mark Feasel as VP of Sales

Updated Category News Views 276

Mission Critical Group Appoints New Vice President of Sales Mission Critical Group (MCG), a leader in critical power infrastructure solutions, is excited to announce the appointment of industry veteran Mark Feasel as the Vice President of Sales in the Commercial and Innovation Division. With this strategic addition, MCG aims to enhance its sales strategy and broaden its...

Continue Reading